NCT03602235 2025-10-21High Dose Ascorbic Acid for Plasma Cell DisordersUniversity of IowaPhase 1 Completed6 enrolled
NCT06425276 2024-05-23Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC TransplantationCASI Pharmaceuticals (China) Co., Ltd.Phase 4 Completed67 enrolled
NCT06082596 2023-10-13Study of BEBT-908 in Subjects With Advanced Hematological TumorsBeBetter Med IncPhase 1 Completed32 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT01660633 2020-04-21Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous TransplantationAcrotech Biopharma Inc.Phase 2 Completed61 enrolled
NCT00925782 2019-12-17PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous TransplantationAcrotech Biopharma Inc.Phase 2 Completed24 enrolled 10 charts
NCT02669615 2018-10-10Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous TransplantationMedical College of WisconsinPhase 2 Completed24 enrolled 6 charts
NCT01148108 2013-03-15Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple MyelomaTelikPhase 2 Completed14 enrolled